Novartis has been actively exploring nanotechnology to revolutionize drug delivery, diagnostics, and personalized medicine. The company's research and development teams are focusing on creating nanoparticles that can precisely target diseased cells, thus minimizing side effects and improving therapeutic outcomes.
